Navigation Links
Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/29/2008

BRIDGEWATER, N.J., May 29 /PRNewswire/ -- Ortho Biotech today announced that two clinical studies for DOXIL(R) (doxorubicin HCl pegylated liposome injection) will be presented at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting at McCormick Place in Chicago from May 30 to June 3, 2008.

"We are pleased that ASCO has accepted these data for presentation at the annual meeting," said Craig Tendler, M.D., Vice President, Medical Affairs, Oncology/Nephrology, Ortho Biotech Products, L.P. "Through our ongoing investigation of DOXIL, Ortho Biotech is committed to oncology clinical research and helping patients fight cancer."
Data from the following studies will be presented:

-- The Effect of Pegylated Liposomal Doxorubicin Plus Bortezomib in

Multiple Myeloma Patients with Renal Insufficiency (Abstract 8562)

Presentation: Saturday, May 31, 8:00 am - 12:00 pm CST, General

Poster Session: Lymphoma and Plasma Cell Disorders, S Hall A1,

Poster 47A

Authors: J. Blade, P. Sonneveld, J. San Miguel, H. Sutherland,

R. Hajek, A. Nagler, A. Spencer, T. Robak, J. L. Harousseau,

R. Z. Orlowski, The DOXIL-MMY-3001 Study Investigators

-- Phase II Trial of Pegylated Liposomal Doxorubicin (PLD), Rituxan,

Cyclophosphamide, Vincristine, and Prednisone in Aggressive B-Cell

Non-Hodgkin's Lymphoma (Abstract 8563)

Presentation: Saturday, May 31, 8:00 am - 12:00 pm CST, General

Poster Session: Lymphoma and Plasma Cell Disorders, S Hall A1,

Poster 47B

Authors: H. Gu, A. Tulpule, N. Berman, C. Duran, S. G. Groshen,

L. Buchanan, W. Boswell, B. Nathwani, A. M. Levine

In addition, the following study was accepted for publication:

-- Activity and Toxicity of Pegylated Liposomal Doxorubicin in

Combination Regimen (DRCOP) for Patients >60 Years Old With Untreate
'/>"/>

SOURCE Ortho Biotech
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
2. Genmab Announces Updates on Phase III Cancer Studies
3. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
4. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
5. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
6. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
7. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
8. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
9. New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
10. N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201
11. Studies Point to Benefits of Personalized Chemotherapy Dose Management in Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- RESMED INC. (NYSE: RMD ) today announced that ... June 30, 2014 results on Thursday, July 31, 2014, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
(Date:7/10/2014)... Quebec , July 10, 2014  Valeant Pharmaceuticals ... VRX) today announced it has completed the sale to ... and Dysport owned or held by Valeant for $1.4 ... with Nestle S.A, which recently completed its acquisition of ... the divestiture of our products to a company that ...
(Date:7/10/2014)... CAESAREA, Israel , July 10, 2014 /PRNewswire/ ... Dario™ Diabetes Management Solution, today announced the appointment ... an independent member of its Board of Directors. ... of legal and business experience to LabStyle as ... director, and legal and corporate governance expert. He ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... Dec. 11 As Warner Chilcott plc (Nasdaq: ... global branded prescription pharmaceuticals business of The Procter & ... Acquisition"), constituted a change of control under a global ... P&G subsidiary acquired by Warner Chilcott and Sanofi-Aventis U.S. ...
... , IRVINE, Calif., Dec. 11 PRO-DEX, INC. (Nasdaq: ... Annual Shareholders Meeting held on December 4, 2009. At the ... Healey, David Holder and Mark Murphy as directors; (ii) approved the ... split if it should elect to do so at any time ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4
(Date:7/13/2014)... published today in The Lancet Neurology ... the long term neurological problems that repeated concussions ... common form of sports-related traumatic brain injury (TBI), ... include dementia, amyotrophic lateral sclerosis, and other neurological ... perhaps more concerning, is that even when the ...
(Date:7/13/2014)... research in Nature Genetics identifies a ... that causes eosinophillic esophagitis (EoE), opening up potential ... food allergy. , EoE is a chronic ... triggered by allergic hypersensitivity to certain foods and ... cells called eosinophils (part of the body,s immune ...
(Date:7/13/2014)... 13, 2014 The North American water storage ... 2013 to $5,450 million by 2018, at a CAGR of ... is expanding at a rapid pace in North America. The ... laws on water & wastewater storage and collection, and the ... market is expanding at a healthy rate in Canada, and ...
(Date:7/13/2014)... According to a new market ... by Component (processor, GPU, DSP, connectivity), Technology Node ... Geography - Forecast and Analysis to 2014-2020", published ... Computing Market is expected to reach $61.70 Billion ... from 2014 to 2020. , Browse 71 market ...
(Date:7/13/2014)... July 13, 2014 Athletes with a ... period from concussions, according to research presented today at ... ) Annual Meeting. The research marks the first of ... on the known physical events that occur after a ... a long allele in the (GT)n genotype were four ...
Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2
... March Issue of Nicotine and Tobacco Research Analyzes Trends, ... date, the majority of research conducted about tobacco use ... heavy smoking. The March 2009 issue of ... light and intermittent smoking. Several of the nation,s preeminent ...
... Dr. Matt Regulski --FORT WORTH, Texas, March 20 ... Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), ... 09 on March 19-21, 2009 at the Renaissance ... considered the premier international multidisciplinary diabetic foot conference ...
... DICK GEPHARDT SERVES ON MMR INFORMATION SYSTEMS, ... MMR Information Systems, Inc. (OTC Bulletin ... subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled ... and electronic safe deposit box storage solutions ...
... well, study says there,s no rush to abandon standard care ... of maggots to treat leg ulcers is similar to standard ... to British researchers. , Debridement (removal of dead tissue ... common part of treatment for leg ulcers, chronic wounds most ...
... SOUTH EASTON, Mass., March 20 Pressure BioSciences, Inc. ... today provided an update on various corporate activities, including ... Innovation Research ("SBIR") Grant from the National Institutes of ... of the Harvard School of Public Health ...
... Nasdaq: SHPGY ), the global specialty biopharmaceutical ... (39) lots of the ADHD patch DAYTRANA (the lots ... below). Shire is taking this action because some ... specification, and as a result, patients and caregivers could ...
Cached Medicine News:Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 2Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 3Health News:New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research 4Health News:Wound Management Technologies Exhibits at Premier International Diabetic Foot Conference DFCon 09 2Health News:Wound Management Technologies Exhibits at Premier International Diabetic Foot Conference DFCon 09 3Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 2Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 3Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 4Health News:Maggots as Good as Gel in Leg Ulcer Treatments 2Health News:Pressure BioSciences, Inc. Provides Corporate Update 2Health News:Pressure BioSciences, Inc. Provides Corporate Update 3Health News:Pressure BioSciences, Inc. Provides Corporate Update 4Health News:Pressure BioSciences, Inc. Provides Corporate Update 5Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 2Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 3Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 4Health News:Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced 5
Inquire...
Inquire...
... The Micro MB for Microhematocrit meets or ... the NCCLS "Standard Procedure for the Determination ... Method" as well as other U.S. and ... Microhematocrit determinations, order Cat. No. 3411 or ...
... two centrifuges -- the world's most popular ... in one reliable, quiet, compact unit. It ... two separate centrifuges!, For your microcentrifuge needs, ... supplies you with the MicroMB centrifuge, microcentrifuge ...
Medicine Products: